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We examined the association between magnetic field (MF) exposure and survival among children with acute lymphoblastic leukaemia
(ALL) treated at 51 Pediatric Oncology Group centres between 1996 and 2001. Of 1672 potentially eligible children under
treatment, 482 (29%) participated and personal 24-h MF measurements were obtained from 412 participants. A total of 386 children
with ALL and 361 with B-precursor ALL were included in the analysis of event-free survival (time from diagnosis to first treatment
failure, relapse, secondary malignancy, or death) and overall survival. After adjustment for risk group and socioeconomic status, the
event-free survival hazard ratio (HR) for children with measurements X0.3mT was 1.9 (95% confidence interval (CI) 0.8, 4.9),
compared to o0.1mT. For survival, elevated HRs were found for children exposed to X0.3mT (multivariate HR¼4.5, 95% CI
1.5–13.8) but based on only four deaths among 19 children. While risk was increased among children with exposures above 0.3mT,
the small numbers limited inferences for this finding.
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Two pooled analyses have reported a positive association between
childhood leukaemia incidence and residential magnetic fields
(MFs) in the upper tail of the exposure distribution (Ahlbom et al,
2000; Greenland et al, 2000). However, in vitro studies and in vivo
animal experiments have not produced evidence of adverse effects
at or near the MF levels associated with residential environments,
nor has a biophysical basis for such effects been established
(NIEHS, 1998; McCann et al, 2000). While earlier studies have
examined potential effects of MF exposure on leukaemia incidence,
MF research has not focused on the progress of disease. We have
examined our hypothesis that if environmental exposure to MF
influences leukaemia blast cells following tumour initiation, effects
on relapse and survival in newly diagnosed acute lymphoblastic
leukaemia (ALL) may be evident.
MATERIALS AND METHODS
Study subjects
Eligibility criteria included a diagnosis of B-precursor, T-cell, or
B-cell ALL within the previous 12 weeks, age between 1 and 15
years, enrolment into a Pediatric Oncology Group (POG) treatment
protocol at a participating centre, and an adult family member who
speaks English, Spanish, or French. Pediatric Oncology Group was
a National Cancer Institute-sponsored consortium that repre-
sented approximately half of all centres that treated childhood
cancer in North America. The study protocol was approved by the
institutional review boards of the Public Health Institute and each
participating treatment centre.
Health professionals at POG centres introduced the study to
eligible children and their families, and obtained written informed
consent from interested families. During the accrual period of
September 1996 to January 2001, 1672 children were being treated
on therapeutic protocols at the 51 participating POG centres.
Twenty nine per cent (482) of children enrolled into our study. The
study group was similar in gender and age to the cohort of eligible
children, although percentages of children by race/ethnicity
differed: white children 72% (cohort) vs 61% (potentially eligible),
Hispanic children 15 vs 21%, African-American children 7 vs 9%.
Families were contacted within 14 days of an agreement to
participate by staff at the Public Health Institute for administration
of a structured telephone interview and explanation of the exposure
assessment process. The interview included questions regarding
sociodemographic characteristics (parental education and family
annual income) and residential history. Ninety-eight per cent (471
out of 482) of families completed the telephone interview.
Data collection
Magnetic field exposure assessment Magnetic field exposure
assessment was initiated after the child completed the initial
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while the child was undergoing consolidation (intensification)
therapy as an outpatient. The EMDEX Lite meter (Enertech
Consultants Campbell, CA, USA), with pictorial and written
instructions (English, Spanish, or French), was forwarded to
families and returned by mail. Personal, 24-h MF exposures were
monitored prospectively, with the first measurement taken shortly
after enrolment and later measurements taken at the beginning of
the second and third year after enrolment. The exposure protocol
and results of demographic and serial MF exposure monitoring
have been previously reported (Foliart et al, 2001, 2002).
A higher-than-expected percentage of families lost or never
returned the meter (8%). Some families were reluctant to use the
meter or had difficultly following the pictorial instructions, with
5% returning the meter with invalid or no data recorded. Based on
follow-up telephone conversations with most of the 70 families
who did not return valid first-year readings, it was clear that the
diagnosis of leukaemia produced tremendous family stress and
disruption, making it difficult to complete the exposure assess-
ment protocol.
Completion of the exposure assessment protocol with return of
viable data decreased during annual serial monitoring: 412
children completed the first monitoring, 304 completed a second
measurement, and 134 completed a third measurement. The mean
time-weighted average (TWA) (0.11–0.13mT) and mean geometric
mean (GM) (0.073–0.082mT) were similar across the three
measurement years (Foliart et al, 2002). Owing to the limited
number of second- and third-year measurements, only the first
year 24-h results were used in our analyses.
A priori, MF exposures were classified in a variety of ways,
including TWA, GM, and two estimates of field stability: rate of
change metric (RCM) and rate of change metric standardised
(RCMS) (Burch et al, 1998). The metrics with the highest year-to-
year correlation were TWA and GM. Rate of change metric and
RCMS were poorly correlated over time (Foliart et al, 2002). Our
final analyses used 24-h exposure classified by TWA and GM.
Clinical data At the time of diagnosis, all children had blood and
bone marrow samples sent to a central reference laboratory at the
University of Alabama, Birmingham, for cytogenetic analysis. For
central assignment to their therapeutic regimen, children were
stratified by immunophenotype and clinical prognostic factors by
the POG Statistical Office at the University of Florida (Gainesville,
FL, USA). For the commonest immunophenotype, B-precursor ALL,
children were enrolled into one of three POG protocols based on
prognostic factors at diagnosis predicting low, standard, or high risk
of treatment failure (Borowitz et al, 1993). For children with B-
precursor ALL enrolled before 2000 (330 out of 361 children), the
National Cancer Institute (NCI) risk group criteria were used to
determine the risk status, based on initial white blood cell count and
age at diagnosis (Smith et al, 1996). In 2000, DNA Index and the
presence of trisomies 4 and 10 were added to the risk stratification.
While the criteria used to identify a child’s risk were refined,
children in a given risk stratum received similar treatment protocols
over the course of the study. Protocols for T- and B-cell ALL did not
change over the course of the enrolment period.
Data analysis
Of the 482 enrolled children, 412 (85%) completed the ques-
tionnaire and first-year MF assessment protocol and 386 (80%)
were included in the analyses. The 26 ineligible children included
13 with missing data regarding response to induction therapy, 10
who did not enrol on a standardised treatment protocol, two with
no follow-up data, and one whose diagnosis was later confirmed
not to be ALL.
The primary outcome for this study was event-free survival, with
additional analyses restricted to overall survival. Kaplan–Meier
curves (Kaplan and Meier; 1958) with log rank tests (Peto et al,
1977) were used to examine the relationship between MF exposure
(TWAo0.1, 0.1–0.19, 0.2–0.29, 40.3mT) and outcome. Event-free
survival was defined as the interval of time from diagnosis to the
date of last contact or to any of the following events that occurred:
failure to attain a complete remission after induction therapy
(Roberts et al, 1997), leukaemia relapse, secondary malignancy, or
death from any cause. Removal for bone marrow transplantation
was considered a censoring event (Pollock et al, 2000). Event-free
survival was tracked through December 2004. Analyses were
performed for all subjects combined and separately for B-
precursor and T-cell ALL patients. Analysis of B-precursor ALL
patients was adjusted by the NCI risk group criteria.
Multivariate analyses were conducted using Cox proportional
hazards regression (Cox, 1972). The association between MF
exposure and outcome, including analyses of trend across MF
strata, as well as the association between other covariates and
outcome, was estimated as the hazards ratio (HR) with 95%
confidence interval (CI). Subjects with MF exposure o0.1mT
constituted the reference group. Regression analyses were adjusted
for a number of potential confounders and effect modifiers: NCI
risk group, race/ethnicity, immunophenotype, and socioeconomic
status (SES). Low SES was defined as annual family income
o$40000 and both parents with less than a college degree.
A number of other covariates were assessed in the secondary
analyses. These included DNA Index, platelet count at diagnosis,
presence of central nervous system involvement at diagnosis,
trisomies 4 and 10, trisomy 21, trisomy 8, and several relatively
rare cytogenetic translocations including t(9;22), t(4;11), and
t(1;19). We examined the impact of these less common prognostic
factors by individually adding them to a Cox regression model that
included a primary MF exposure category and the NCI risk group.
Table 1 Race, ethnicity, and socioeconomic status of cohort
a
Socioeconomic status Annual income Maternal education Paternal education
No. (%) High Low 4$40000 o$40000 Some college pHigh school Some college pHigh school
White 290 (75) 239 (86) 39 (14) 150 (53) 132 (47) 196 (69) 88 (31) 182 (65) 98 (35)
African American 20 (5) 11 (73) 4 (27) 1 (5) 17 (94) 14 (74) 5 (26) 4 (27) 11 (73)
Hispanic 50 (13) 24 (56) 19 (44) 11 (22) 37 (77) 19 (39) 30 (61) 12 (27) 32 (73)
Native American 2 (0.5) 2 (100) 0 0 2 (100) 1 (50) 1 (50) 1 (50) 1 (50)
Asian 11 (3) 10 (100) 0 9 (90) 1 (10) 11 (100) 0 10 (91) 1 (9)
Hawaiian 9 (2) 6 (75) 2 (25) 3 (33) 6 (67) 5 (56) 4 (44) 4 (50) 4 (50)
Other 4 (1) 2 (50) 2 (50) 2 (50) 2 (50) 2 (50) 2 (50) 2 (50) 2 (50)
Response missing 0 26 13 8 22
aPer cent in parentheses, based on total with available information. A total of 386 families completed the telephone questionnaire, but answers to some queries were not known
by respondents.
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Of the 386 children included in the analysis, 71% were less than 6
years old. Boys slightly outnumbered girls (52%). Table 1 presents
details of race/ethnicity and SES. Most children (75%) were white;
41% were classified as having low SES. Annual family income,
paternal education, and, to a lesser extent, maternal education
varied widely by race and ethnic group (Table 1).
Most children completed the MF monitoring session shortly
after diagnosis: 48% (186) within 2 months following diagnosis
and 86% (332) within 4 months. The mean TWA was similar to
that in other North American studies: 0.1mT, with a 95th percentile
value of 0.3mT (Kaune and Zaffanella, 1994; Linet et al, 1997;
Deadman et al, 1999).
Table 2 summarises the MF exposure findings. Only 19 children
(5%) had a TWAX0.3mT and 14 (4%) had a GMX0.3mT. A higher
percentage of non-white compared with white children (7.3 vs
4.1%) had TWA exposures X0.3mT (odds ratio¼1.8, 95% CI 0.70,
4.77).
The median duration of follow-up among survivors was 5.07
years. There were 73 failure events among all children and 70
failure events among the 361 children with B-precursor ALL. There
was a total of 30 deaths, of which 28 occurred among children with
B-precursor ALL. In only one child was death the first failure
event. For the 29 other children, the initial failure event was relapse
(n¼25) or secondary malignancy (n¼4).
Figure 1 presents the Kaplan–Meier estimate of event-free
survival for children with B-precursor ALL, stratified by 24-h TWA
MF exposures (log rank test P¼0.54). Estimates using GM were
similar and are not presented. Owing to small numbers, figures for
total survival and T-cell ALL are not presented.
Cox proportional hazards regression analyses of survival are
presented in Table 3. No statistically significant trend was noted
between increasing exposure to MF and poorer event-free survival
(P¼0.5). Five failures were observed among children exposed to
X0.3mT, four due to relapse and one due to secondary malignancy
(four died during follow-up). Hazard ratios for children in the
highest exposure category of X0.3mT were increased in both
univariate and multivariate analyses. In univariate analysis, the
event-free survival HR for exposure X0.3mT was 1.66, 95% CI
0.66, 4.18. Multivariate analyses of B-precursor ALL, adjusted for
age at diagnosis and initial white blood cell count (NCI risk group)
and SES, reported an HR for exposure X0.3mT of 1.92, 95% CI
0.75, 4.90. Of the five failures in this exposure group, two occurred
among the 11 white children and three occurred among the seven
non-white children. Although failures were more common among
non-white children, small numbers prevented us from adequately
examining race-specific risks.
For overall survival, HRs were significantly elevated among
children exposed to X0.3mT in both univariate and multivariate
analyses, based on four deaths (two in white children and two in
non-white children). In univariate analysis, the HR was 3.39, 95%
Table 2 Summary of 24-h time-weighted average (TWA) and geometric
mean (GM) magnetic field exposure results
TWA GM
Exposure (lT) Frequency % Frequency %
o0.1 251 65 294 76
0.1–0.19 95 25 67 17
0.2–0.29 21 5 11 3
0.3–0.39 7 2 10 3
0.4–0.49 7 2 4 1
0.5–0.59 1 0.3 0 0
X0 . 6 41 00
Total 386 386
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Figure 1 Kaplan–Meier estimates for event-free survival among children
with B-precursor ALL, stratified by 24-h TWA MF exposure (log rank test
P¼0.054).
Table 3 Association of magnetic field exposure and outcome: Cox proportional hazards regression analyses
Event-free survival Survival
Variable No. of cases No. failed
a HR 95% HR CI
b P
c No. of cases No. failed HR 95% HR CI P
c
Univariate analysis 386 73 0.4 386 30 0.2
o0.1mT 251 42 1.00 251 17 1.00
0.1–0.19mT 95 22 1.47 0.88 2.46 95 8 1.27 0.55 2.93
0.2–0.29mT 21 4 1.15 0.41 3.20 21 1 0.68 0.09 5.13
X0.3mT 19 5 1.66 0.66 4.18 19 4 3.39 1.14 10.06
Multivariate analysis
B-precursor
d 361 70 0.5 361 28 0.06
NCI risk group 1.76 1.01 2.88 2.78 1.29 5.96
SES 0.98 0.52 1.83 1.61 0.68 3.82
o0.1mT 235 41 1.00 235 16 1.00
0.1–0.19mT 89 20 1.25 0.72 2.19 89 7 1.16 0.47 2.84
0.2–0.29mT 19 4 1.32 0.47 3.71 19 1 0.85 0.11 6.40
X0.3mT 18 5 1.92 0.75 4.90 18 4 4.53 1.49 13.76
aFailure events defined as failure to attain complete response during induction therapy, leukaemia relapse, secondary cancer, or death.
bHR¼hazard ratio; CI¼confidence
interval.
cTest of trend for time-weighted average magnetic field exposure level.
dAdjusted for National Cancer Institute (NCI) risk group and socioeconomic status (SES).
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1.49, 13.76. In the multivariate analysis, there was a marginal trend
(P¼0.06) between increasing exposure category and deaths,
although the number of deaths was small, with only one observed
among the 19 children exposed to X0.2–0.29mT.
As expected, children in the higher NCI risk group were at an
increased risk of poor outcome for both event-free survival and
total survival. Socioeconomic status was not associated with
outcome. No significant first-order interaction terms were
observed between MF exposure and the following covariates:
DNA Index, platelet count at diagnosis, presence of central
nervous system blast cells at diagnosis, and presence of transloca-
tions or trisomies (data not presented).
DISCUSSION
Although other studies have investigated MF exposure as a risk
factor for incident ALL, this is the first study to address MF
exposure and long-term survival among children with ALL.
Strengths of the study include its prospective cohort design, use
of centralised review of malignancy and biologic markers,
inclusion of children from a wide geographic area, personal MF
dosimetry, and the length and completeness of follow-up. Because
failure events are most likely to occur within the first 5 years
following diagnosis (Pollock et al, 2000), the study had an adequate
duration of follow-up to capture most outcome events.
Three limitations of our study are noteworthy. As has been seen
in earlier studies, only 5% of the cohort (19 children) had a TWA
above 0.3mT (Kaune and Zaffanella, 1994; Linet et al, 1997;
Deadman et al, 1999). Thus, we had limited ability to evaluate
outcome among children exposed to more than 0.3mT and could
perform no meaningful analyses above 0.4mT. Secondly, less than
one-third of potentially eligible children enrolled into our study,
with lower participation rates among non-white children. The
limited number of non-white children prevented meaningful
multivariate analyses by racial/ethnic subgroups. Finally, our
survival analyses were based on first-year MF exposure assess-
ments. In an analysis of the subset of 304 children with two or
more annual measurements, we found that first-year GM and TWA
can serve as an estimate of exposure among residentially stable
children (Foliart et al, 2002). However, a single measurement was
less useful among children who changed residences. Twelve per
cent of children with first-year measurements moved during the
exposure assessment protocol. The total number of children who
changed residences during the entire course of follow-up is
unknown. The single assessment of MF exposure in residentially
mobile children may not be an adequate surrogate of MF exposure
over the study’s extended follow-up period.
The focus of our study was the possible role of MF exposure as
an independent predictor of event-free and overall survival. The
number of failures was small: four among children exposed to
X0.2–0.29mT and five among children exposed to X0.3mT. For
overall survival, the HRs were significantly elevated among
children exposed to X0.3mT for both univariate and multivariate
analyses. The multivariate HR (4.5) was based on only four deaths,
yielding a wide CI (1.5, 13.8). No consistent or statistically
significant trend was noted between increasing exposure to MF
and event-free survival or risk of death. Although we report poorer
survival among children with the highest MF exposure category,
clinical inferences are limited, with results possibly attributable to
chance alone. Independent confirmation is needed, as our study is
the first to look at relapse and survival and thus our findings can
be viewed only as hypothesis generating.
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